Pharma Dividend: Small Cap Stock Sets Record Date, Shares Jump Over 6%

Shares of small cap pharmaceuticals sector, Bajaj Healthcare witnessed a rally of over 6% intraday today after the company fixed September 23 as the record date for dividend a day before. Bajaj Healthcare shares soared 29% in last 2-weeks and 116% in last 3-years. Check details below:

Bajaj Healthcare Fixes Record Date For Dividend: According to the BSE filing of Bajaj Healthcare company, "Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Saturday, September 23, 2023 is fixed as the record date for the purpose of payment of dividend, if approved by the shareholders at the ensuing Annual General Meeting."

Bajaj Healthcare Stock Outlook & Return: Current market price of Bajaj Healthcare share is Rs 397.90 per share with intraday gain of over 6% today. Its 52-week high price is Rs 457.55 per share and 52-week low price is Rs 245.05 per share, respectively. The company has a market capitalisation of Rs 1098.14 crore. Bajaj Healthcare shares offered its shareholders return of 36% in last 3-months, gained 15% in last 6-months, fell 12% YTD, soared 2% in last 1-year, and gave return of 265% in last 5-years.

Bajaj Healthcare Financial Outlook: The company for the quarter ended June 30, 2023 announced its standalone total income at Rs 129.95 crore, down 18.35% as against its last quarter total income of Rs 159.17 crore. It announced its recent quarter net profit after tax in negative at Rs -48.21 crore.

Bajaj Healthcare About: Bajaj Healthcare Ltd is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness, according to its official website.

Disclaimer

The stock just highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.